On the post-quantum side, Cryptolib now includes hardware-accelerated implementations of three families of NIST-standardized PQC algorithms: ML-KEM, ML-DSA, and SLH-DSA. The SLH-DSA (SPHINCS+) ...

MILPITAS, Calif., March 15, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the fourth quarter and full year of ...

In December, David Franklyn gave us Argonaut's top gold developers. Four months on, he's checking in to see how those ... Read More The post Argonaut Algorithm: How the story is playing out for David ...

Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...

Pomdoctor Limited (Pomdoctor or the Company) (NASDAQ: POM), a leading online medical services platform for chronic diseases ...

Jenny Anderson, a journalist, is author of the Substack “How to Be Brave.” Rebecca Winthrop is director of the Center for Universal Education at the Brookings Institution and author of the newsletter ...

VANCOUVER, BC / ACCESS Newswire / March 11, 2026 / Algo Grande Copper Corp. ("Algo Grande") (TSXV:ALGR)(OTC:KNDYF)(FRA:KM00) ...

Where do AI systems lose confidence in your content? Discovery, selection, crawling, rendering, and indexing hold the answer.

Four-legged robots that scramble up stairs, stride over rubble, and stream inspection data — no preorder, no lab coat ...

CTA has delivered strong absolute returns. From inception through 02/28/26, CTA's NAV total cumulative return was 51.52%, translating to an annualized return of 11.01%.

Parrot CEO & founder Henri Seydoux together with SEALSQ General Manager Bernard Vian and EMEA Sales Director Fabien Treillaud at Embedded World, Nuremberg, on March 11, 2026. SEALSQ Corp (Nasdaq: LAES ...

Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...